9-ING-41

(Synonyms: Elraglusib)
6 Cited Publications
고객리뷰

Based on 6 publication(s) in Google Scholar

9-ING-41 (Elraglusib) is a maleimide-based ATP-competitive and selective glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 of 0.71 μM. 9-ING-41 significantly leads to cell cycle arrest, autophagy and apoptosis in cancer cells. 9-ING-41 has anticancer activity and has the potential for enhancing the antitumor effects of chemotherapeutic agents.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • Purity: 99.13%
  • CAS No.: 1034895-42-5
  • 화학식: C22H13FN2O5
  • 분자량:404.35
  • 보관:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 2 years , -20°C, 1 year
  • Biological Activity
  • Chemical Information
  • 용액&용해도
  • 순도&문서
  • References
  • Help & FAQs
You May Still Need
Customer Validation & Images
Cell Proliferation/Viability AssayCell Imaging/StainingHistological Imaging/StainingIHC
  • Cell Proliferation/Viability Assay
  • Cell Imaging/Staining
  • Cell Proliferation/Viability Assay
  • Histological Imaging/Staining
  • IHC

All GSK-3 Isoforms

More
MOQ
Minimum order quantity
100 mg

견적 받기 해외재고보유

Other size
견적 받기
Please select quantity
Amount: USD 0.00